前列腺特异性抗原检测的启动与共享决策:2000年与2015年全国健康访谈调查结果
该研究分析2000年和2015年全国健康访谈调查数据,发现过去一年接受PSA检测的男性中,医生首先建议检测的年龄标化患病率从2000年的72.3%升至2015年的84.9%;2015年≥70岁男性近90%的PSA筛查由医生建议;不足三分之一的男性报告曾参与讨论PSA检测的利弊。
要点
- 2015年医生首先建议PSA检测的年龄标化患病率84.9%,显著高于2000年的72.3%。
- 2015年≥70岁男性近90%的PSA筛查由医生建议。
- 不足三分之一男性报告曾讨论PSA检测的利弊。
核心结论
- 过去一年接受PSA检测的男性多数报告医生首先建议检测,包括≥70岁男性。
- 研究指出临床实践中PSA检测前开展共享决策面临挑战和需求。
研究设计与样本
- 分析2000年和2015年全国健康访谈调查数据。
- 计算两年医生启动PSA检测的年龄标化患病率。
- 2015年使用逻辑回归计算医生启动PSA检测的调整患病率比。
- 计算曾讨论检测利弊的患病率。
主要发现
- 医生启动PSA检测的年龄标化患病率2015年(84.9%)显著高于2000年(72.3%)。
- 2015年≥70岁男性近90%的PSA筛查由医生建议。
- 医生启动PSA检测与2种及以上合并症及患者就诊医生次数呈正相关。
- 不足三分之一男性报告曾参与讨论PSA检测的利弊。
关键数值与推荐
- 医生启动PSA检测年龄标化患病率:2000年72.3%,2015年84.9%。
- 2015年≥70岁男性近90%的PSA筛查由医生建议。
- 不足三分之一男性报告曾讨论PSA检测的利弊。
临床怎么用
- 全科医生启动PSA检测前应主动开展共享决策,讨论检测利弊。
- 对≥70岁男性等高龄人群,医生建议PSA检测时需特别关注共享决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSES: Despite recommendations against prostate cancer screening with prostate-specific antigen (PSA) tests, about one-fourth of men age ≥40 years received PSA tests in 2015. This study aimed to answer 3 questions for men who had a PSA test in the past year: (1) What percentage of these men received the test first suggested by physicians? (2) What factors were associated with physician-initiated PSA testing (PIPT) versus patient/someone else-initiated testing? (3) What percentage of patients ever had shared decision-making when tests were initiated by physicians? METHODS: We analyzed the 2000 and 2015 National Health Interview Survey data. We calculated age-standardized prevalence of PIPT for both years. For 2015, we used logistic regression to calculate adjusted prevalence ratios for PIPT. We also calculated the prevalence of ever discussing both advantages and disadvantages. RESULTS: The age-standardized prevalence of PIPT was significantly higher in 2015 (84.9%) than in 2000 (72.3%). In 2015, nearly 90% of PSA screenings for men aged ≥70 years were suggested by physicians. PIPT was positively associated with 2 or more comorbid conditions and number of patient visits to the doctor. Less than one-third of men reported they had ever participated in a discussion of advantages and disadvantages of PSA testing. CONCLUSIONS: The majority of men who had PSA testing in the past year reported that their physicians were the first to suggest testing, including men aged ≥70 years. Our study also points to the challenges and needs in conducting shared decision-making before PSA testing in clinical practice.
引用
- Li J, Ding H, Richards TB, et al. Prostate-Specific Antigen Testing Initiation and Shared Decision-Making: Findings from the 2000 and 2015 National Health Interview Surveys. J Am Board Fam Med. 2018. PMID: 29986994. doi:10.3122/jabfm.2018.04.170448
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。